Ulna Length in Black Children

Ulna Length in Otherwise Healthy Children (With the Exception of Mild to Moderate Asthma) Clinical Trial

— ULNOIR  

Official title:

Prediction of Childhood Pulmonary Function Using Ulna Length in Children of Sub-saharian or Caribbean Ethnicity

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04062422
• Other study ID #: N°IDRCB 2017-A02962-51
• Status: Completed
• Start date: April 16, 2018
• Est. completion date: April 28, 2019

Study information

• Verified date: August 2019
• Source: Assistance Publique - Hôpitaux de Paris
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Height measurement is unreliable when neuromuscular weakness or spinal deformity is present. The aim of this study was to accurately predict pulmonary function from a limb segment (ulna) measurement that is precise and reproducible. Equations are available in caucasian children but are not available in children of sub-saharian or caribbean ethnicity, which was the aim of the study. To this end, 350 black children referred for pulmonary function testing for asthma follow-up will be included.

Description:

Ulna (dominant and non-dominant arm), height measurement in 350 asthmatic children of sub-saharian or caribbean ethnicity (both parents). Repeatability analysis (ulna and height) for the first fifty children. Recording of pulmonary function tests results (spirometry, resistance measurements)

Recruitment information / eligibility

• Status: Completed
• Enrollment: 350
• Est. completion date: April 28, 2019
• Est. primary completion date: March 28, 2019
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• age: 3 to 18 years old, two parents of sub-saharian or caribbean origin, referred for asthma suspicion or follow-up.

Exclusion Criteria:

• chronic disease excepting asthma, prematurity (<36 GW), steroid (>3/year), high dosage of inhaled steroid

Related Conditions & MeSH terms

• Ulna Length in Otherwise Healthy Children (With the Exception of Mild to Moderate Asthma)

Locations

Country	Name	City	State
France	Robert Debre Hospital	Paris

Sponsors (1)

Lead Sponsor	Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

References & Publications (1)

Beydon N, Leye F, Bokov P, Delclaux C. Prediction of height using ulna length in African-Caribbean children. Pediatr Pulmonol. 2022 Sep;57(9):2032-2039. doi: 10.1002/ppul.25972. Epub 2022 May 21. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Ulna length		12 hours